These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 9401802)

  • 1. Malignant melanoma in the CNS, subtyping and immunocytochemistry.
    Bär H; Schlote W
    Clin Neuropathol; 1997; 16(6):337-45. PubMed ID: 9401802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas?
    Kaleem Z; Lind AC; Humphrey PA; Sueper RH; Swanson PE; Ritter JH; Wick MR
    Mod Pathol; 2000 Mar; 13(3):217-22. PubMed ID: 10757331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical characteristics of melanoma.
    Ohsie SJ; Sarantopoulos GP; Cochran AJ; Binder SW
    J Cutan Pathol; 2008 May; 35(5):433-44. PubMed ID: 18399807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological, immunohistochemical, and ultrastructural study of 13 cases of melanotic schwannoma.
    Zhang HY; Yang GH; Chen HJ; Wei B; Ke Q; Guo H; Ye L; Bu H; Yang K; Zhang YH
    Chin Med J (Engl); 2005 Sep; 118(17):1451-61. PubMed ID: 16157048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reactivity of five different antibodies with benign and malignant melanocytic lesions].
    Plótár V; Szentirmay Z; Orosz Z
    Magy Onkol; 2008 Dec; 52(4):363-73. PubMed ID: 19068464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary melanocytomas of the spinal cord: a report of seven cases.
    Glick R; Baker C; Husain S; Hays A; Hibshoosh H
    Clin Neuropathol; 1997; 16(3):127-32. PubMed ID: 9197936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anorectal malignant melanoma: morphologic and immunohistochemical features.
    Chute DJ; Cousar JB; Mills SE
    Am J Clin Pathol; 2006 Jul; 126(1):93-100. PubMed ID: 16753594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
    Gleason BC; Nascimento AF
    Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas.
    Yu CH; Chen HH; Liu CM; Jeng YM; Wang JT; Wang YP; Liu BY; Sun A; Chiang CP
    J Oral Pathol Med; 2005 Oct; 34(9):540-5. PubMed ID: 16138892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of S100A6 in cellular neurothekeoma: clinicopathologic and immunohistochemical analysis of 31 cases.
    Plaza JA; Torres-Cabala C; Evans H; Diwan AH; Prieto VG
    Am J Dermatopathol; 2009 Jul; 31(5):419-22. PubMed ID: 19542912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
    Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
    Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the proliferation marker MIB-1 in the prognosis of cutaneous malignant melanoma.
    Hazan C; Melzer K; Panageas KS; Li E; Kamino H; Kopf A; Cordon-Cardo C; Osman I; Polsky D
    Cancer; 2002 Aug; 95(3):634-40. PubMed ID: 12209757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear morphometry of MIB-1 positive and negative tumor cells in primary and metastatic malignant melanoma of the skin.
    Karbowniczek M; Chosia M; Domagała W
    Pol J Pathol; 1999; 50(4):235-41. PubMed ID: 10721263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic imbalance in the diagnosis of benign, atypical and malignant Spitz tumours.
    van Dijk MC; Rombout PD; Mooi WJ; van de Molengraft FJ; van Krieken JH; Ruiter DJ; Ligtenberg MJ
    J Pathol; 2002 Jun; 197(2):170-8. PubMed ID: 12015740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
    de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
    Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary balloon cell malignant melanoma of the right temporo-parietal region arising from meningeal naevus.
    Adamek D; Kaluza J; Stachura K
    Clin Neuropathol; 1995; 14(1):29-32. PubMed ID: 7729077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary malignant melanoma of the ovary: a report of 9 definite or probable cases with emphasis on their morphologic diversity and mimicry of other primary and secondary ovarian neoplasms.
    McCluggage WG; Bissonnette JP; Young RH
    Int J Gynecol Pathol; 2006 Oct; 25(4):321-9. PubMed ID: 16990706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin-dependent kinase inhibitory protein expression in human choroidal melanoma tumors.
    Mouriaux F; Maurage CA; Labalette P; Sablonnière B; Malecaze F; Darbon JM
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2837-43. PubMed ID: 10967035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant melanoma with neuroendocrine differentiation: clinical, histological, immunohistochemical and ultrastructural features of three cases.
    Eyden B; Pandit D; Banerjee SS
    Histopathology; 2005 Oct; 47(4):402-9. PubMed ID: 16178895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.